Rushing coronavirus drugs, vaccines to market is a risky venture, experts say
Assistant Professor Patricia Zettler was recently quoted in an S&P Global article titled, “Rushing coronavirus drugs, vaccines to market a risky venture, experts say.”
“We may be undermining the importance, in general, of doing the hard work to study potential therapies and vaccines to understand what works and what doesn’t, even outside the COVID-19 context,” she said.
An expert in health law, Zettler came to Moritz in 2019 from Georgia State University. Prior her time at GSU, she served as associate chief counsel for the FDA.